Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 2 of 39

  1. 22590

    Disc Medicine

    Metastatic cervical cancer

    approved small molecule active

    1 trial

  2. 23-valent pneumococcal polysaccharide vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab completed

    1 trial

  3. 25-0256

    United Therapeutics Europe Ltd

    Frostbite

    approved small molecule active

    1 trial

  4. 2wIPV+1sIPV

    Biotech Pharmaceutical Co.,

    Poliomyelitis

    approved mab active

    1 trial

  5. 2wIPV+1sIPV

    Sinovac Research and Development Co.,

    Poliomyelitis

    approved mab active

    1 trial

  6. 3 % Minoxidil lotion

    Hospital Authority, Hong Kong

    Beard Enhancement

    approved small molecule completed

    1 trial

  7. 30% Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atelectasis

    approved small molecule completed

    1 trial

  8. 30%Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atelectasis, Postoperative

    approved small molecule completed

    1 trial

  9. 300128

    HALEON AUSTRALIA PTY LTD

    Mild/non-serious osteoarthritis (OA) of the knee.

    approved small molecule active

    1 trial

  10. 300889

    GlaxoSmithKline

    Incident dementia

    approved small molecule active

    1 trial

  11. 37.5mg Pregabalin + 75mg Pregabalin

    The First People's Hospital of Lianyungang

    Pain, Postoperative

    approved small molecule completed

    1 trial

  12. 400IU cholecalciferol and 500mg of elemental calcium as calcium carbonate

    BRIGHT MINDS BIOSCIENCES INC.

    Benign Paroxysmal Positional Vertigo

    approved small molecule completed

    1 trial

  13. 50 mcg Duramorph+ EXPAREL + multi-modal pain regimen

    Pacira Ireland Limited

    Elective Cesarean Section

    approved small molecule completed

    1 trial

  14. 50,000 Units Ergocalciferol

    United Therapeutics Europe Ltd

    Pruritis

    approved small molecule completed

    1 trial

  15. 5000 volunteers (6-35 months)-EV71 vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  16. 54659

    Disc Medicine

    Hand eczema

    approved small molecule active

    1 trial

  17. 6-month clopidogrel therapy

    Hospital Authority, Hong Kong

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  18. 60 µg dose hepatitis B vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccination

    approved mab completed

    1 trial

  19. 60 µg dose hepatitis B vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccine

    approved mab completed

    1 trial

  20. 80% Oxygen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oxygenation Index

    approved small molecule active

    1 trial

  21. 844700336/0156/1

    Lacuna Pharma Pty Ltd

    Erectile dysfunction

    approved small molecule active

    1 trial

  22. 99mTc-Macro Albumin Aggregate

    BRIGHT MINDS BIOSCIENCES INC.

    Carcinoma

    approved small molecule completed

    1 trial

  23. A-101 Topical Solution

    Aclaris Therapeutics

    Seborrheic Keratosis

    approved small molecule completed

    1 trial

  24. A8081075

    Pfizer Australia Pty Ltd

    This Master Protocol for Crizotinib Continuation Sub-Studies has been designed to provide continued treatment access for eligible participants who continue to derive clinical benefit from study intervention in a Pfizer sponsored crizotinib parent study that will be closed

    approved small molecule active

    1 trial

  25. AA-HPP-407

    Alexion Europe SAS

    HYPOPHOSPHATASIA

    approved small molecule active

    1 trial

  26. AB.OH.2025

    The George Institute

    Infectious diseases

    approved small molecule active

    1 trial

  27. ABBV-066, DEUCRAVACITINIB

    AbbVie Deutschland GmbH & Co. KG

    Plaque Psoriasis

    approved small molecule active

    1 trial

  28. ACEI / ARB+finerenone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Henoch Schönlein Purpura Nephritis

    approved small molecule active

    1 trial

  29. ACETYLSALICYLIC ACID

    The George Institute

    Obstetrics – Preeclampsia

    approved small molecule active

    1 trial

  30. ACETYLSALICYLIC ACID for Peripheral Arterial Disease

    Disc Medicine

    Peripheral Arterial Disease

    approved small molecule active

    1 trial

  31. ACETYLSALICYLIC ACID, PRASUGREL

    Cardiol Therapeutics

    St-Elevated Myocardial Infartion

    approved small molecule active

    1 trial

  32. AD-4833 15 mg

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    1 trial

  33. ADALIMUMAB , INFLIXIMAB

    Disc Medicine

    Crohn's disease Ulcerative colitis

    approved small molecule active

    1 trial

  34. ADIPGEN

    The George Institute

    Knee Osteoarthritis

    approved small molecule active

    1 trial

  35. ADVAGRAF

    Astellas Pharma Inc

    Renal Transplantation

    approved small molecule completed

    1 trial

  36. ADVATE

    Takeda

    Hemophilia A

    approved mab completed

    1 trial

  37. ADZENYS XR-ODT

    AYTU BIOPHARMA, INC

    Attention Deficit Hyperactivity Disorder

    approved small molecule terminated

    1 trial

  38. AGAMREE 40 mg/ml oral suspension

    Lacuna Pharma Pty Ltd

    Duchenne Muscular Dystrophy

    approved small molecule active

    1 trial

  39. AGEE cream

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule terminated

    1 trial

  40. AL (Coartem)

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial

  41. ALA

    The First People's Hospital of Lianyungang

    Actinic Keratoses

    approved small molecule active

    1 trial

  42. ALLERDOG

    The George Institute

    Allergic rhinitis due to dog allergy

    approved small molecule active

    1 trial

  43. AMINOHIPPURIC ACID for Chronic Kidney Disease Kidney Failure

    Disc Medicine

    Chronic Kidney Disease Kidney Failure

    approved small molecule active

    1 trial

  44. AMOXICILINA NORMON 1000 mg Comprimidos EFG

    The George Institute

    Infective endocarditis

    approved small molecule active

    1 trial

  45. AMOXICILLIN

    Pari Pharma GmbH

    Adults diagnosed with lower limbs erysipelas

    approved small molecule active

    1 trial

  46. AN69ST hemofilter

    The First People's Hospital of Lianyungang

    Critical Ill Patients

    approved other completed

    1 trial

  47. ANGELO

    The George Institute

    Obesity

    approved small molecule active

    1 trial

  48. ANM T30 CR®-System

    Adaptive Biotechnologies Corp

    Tinnitus

    approved other completed

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.